CT with hepatic arterioportography as a pretreatment examination for hepatocellular carcinoma patients: A randomized controlled trial

American Journal of Gastroenterology

Volumn 108, Issue 8, 2013, Pages 1305-1313

  Ohki, Takamasa ^a,b   Tateishi, Ryosuke ^a   Akahane, Masaaki ^a   Mikami, Shintaro ^a   Sato, Masaya ^a   Uchino, Koji ^a   Arano, Toru ^a   Enooku, Kenichiro ^a   Kondo, Yuji ^a   Yamashiki, Noriyo ^a   Goto, Tadashi ^a   Shiina, Shuichiro ^a   Yoshida, Haruhiko ^a   Matsuyama, Yutaka ^a   Omata, Masao ^c   Ohtomo, Kuni ^a   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUI MEMORIAL HOSPITAL   (Japan)

^c Yamanashi Prefectural Hospital Organization   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTERIAL PORTOGRAPHY; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; LIVER FUNCTION; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OVERALL SURVIVAL; PORTAL PHLEBOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; TUMOR THROMBUS;

AGED; ANGIOGRAPHY; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CONTRAST MEDIA; DISEASE PROGRESSION; EMBOLIZATION, THERAPEUTIC; ENDPOINT DETERMINATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PORTOGRAPHY; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84881123026     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.109     Document Type: Article

References (38)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50.
2. Kiyosawa K, Umemura T, Ichijo T et al. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 2004;127:S17-26.
3. Itai Y, Matsui O. Blood fl ow and liver imaging. Radiology 1997;202:306-14.
4. Matsui O. Detection and characterization of hepatocellular carcinoma by imaging. Clin Gastroenterol Hepatol 2005;3:S136-40.
5. Teratani T, Yoshida H, Shiina S et al. A novel display of reconstruction computed tomography for the detection of small hepatocellular carcinoma. Liver Int 2004;24:619-24.
6. Fujishima T, Yoshida H, Obi S et al. Analysis of factors infl uencing hepatocellular carcinoma detection: effi cient use of computed tomography during arterial portography and during hepatic arteriography. J Gastroenterol 2005;40:266-73.
7. Sangiovanni A, Manini MA, Iavarone M et al. Th e diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 2010;59:638-44.
8. Murakami T, Oi H, Hori M et al. Helical CT during arterial portography and hepatic arteriography for detecting hypervascular hepatocellular carcinoma . AJR Am J Roentgenol 1997;169:131-5.
9. Kanematsu M, Hoshi H, Imaeda T et al. Detection and characterization of hepatic tumors: value of combined helical CT hepatic arteriography and CT during arterial portography. AJR Am J Roentgenol 1997;168:1193-8.
10. Irie T, Takeshita K, Wada Y et al. CT evaluation of hepatic tumors: comparison of CT with arterial portography, CT with infusion hepatic arteriography, and simultaneous use of both techniques. AJR Am J Roentgenol 1995;164:1407-12.
11. Small WC, Mehard WB, Langmo LS et al. Preoperative determination of the resectability of hepatic tumors: effi cacy of CT during arterial portography. AJR Am J Roentgenol 1993;161:319-22.
12. Soyer P, Levesque M, Elias D et al. Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography. Radiology 1992;183:541-4.
13. Soyer P, Levesque M, Elias D et al. Preoperative assessment of resectability of hepatic metastases from colonic carcinoma: CT portography vs sonography and dynamic CT. AJR Am J Roentgenol 1992;159:741-4.
14. Matsui O, Kadoya M, Suzuki M et al. Work in progress: dynamic sequential computed tomography during arterial portography in the detection of hepatic neoplasms. Radiology 1983;146:721-7.
15. Sherman M, Klein A. AASLD single-topic research conference on hepatocellular carcinoma: conference proceedings. Hepatology 2004;40:1465-73.
16. Tateishi R, Shiina S, Ohki T et al. Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation. J Gastroenterol 2009;44 (Suppl 19):142-6.
17. Ebara M, Ohto M, Sugiura N et al. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients. J Gastroenterol Hepatol 1990;5:616-26.
18. Livraghi T, Giorgio A, Marin G et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101-8.
19. Shiina S, Tagawa K, Niwa Y et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol 1993;160:1023-8.
20. Seki T, Wakabayashi M, Nakagawa T et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 1999;85:1694-702.
21. Rossi S, Di Stasi M, Buscarini E et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996;167:759-68.
22. Allgaier HP, Deibert P, Zuber I et al. Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet 1999;353:1676-7.
23. Livraghi T, Goldberg SN, Lazzaroni S et al. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210:655-61.
24. Curley SA, Izzo F, Ellis LM et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381-91.
25. Shiina S, Tateishi R, Arano T et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 2012;107:569-77;quiz 578.
26. Jang HJ, Lim JH, Lee SJ et al. Hepatocellular carcinoma: are combined CT during arterial portography and CT hepatic arteriography in addition to triple-phase helical CT all necessary for preoperative evaluation? Radiology 2000;215:373-80.
27. Rennie D. CONSORT revised-improving the reporting of randomized trials. JAMA 2001;285:2006-7.
28. Efron B. Forcing a sequential experiment to be balanced. Biometrika 1971;58:403.
29. Kitao A, Zen Y, Matsui O et al. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography-radiologic-pathologic correlation. Radiology 2009;252:605-14.
30. Tateishi R, Shiina S, Teratani T et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005;103:1201-9.
31. Goldberg SN, Grassi CJ, Cardella JF et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 2009;20:S377-90.
32. Sacks D, McClenny TE, Cardella JF et al. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2003;14:S199-202.
33. Ohki T, Tateishi R, Akahane M et al. Characteristics of hepatocellular carcinoma nodules newly detected by computed tomography during arteriography and arterial portography: preliminary report of a randomized controlled trial. Hepatol Int 2011 (e-pub ahead of print).
34. Minami Y, Kudo M. Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma. World J Gastroenterol 2011;17:4952-9.
35. Numata K, Fukuda H, Morimoto M et al. Use of fusion imaging combining contrast-enhanced ultrasonography with a perfl ubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma. Eur J Radiol 2012;81:2746-53.
36. Masuzaki R, Shiina S, Tateishi R et al. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma. J Gastroenterol Hepatol 2011;26:759-64.
37. Ichikawa T, Saito K, Yoshioka N et al. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol 2010;45:133-41.
38. Hatanaka K, Kudo M, Minami Y et al. Diff erential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008 ; 51 (Suppl 1):61-9.